All posts tagged in makes it the largest overseas drugmaker in terms of sales in the country. The company has previously targeted Chinese biotech firms for acquisitions and identified China as a key growth market

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy